Home

Alteogen, Inc. (196170)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Alteogen, Inc. (196170)

Go deeper and ask any question about 196170

Company Performance

Current Price

as of Sep 13, 2024

$240.76

P/E Ratio

N/A

Market Cap

$12.83B

Description

Alteogen, Inc. engages in the development, manufacture, and sale of biopharmaceuticals and anticancer drugs. Its products include technologies for anti-breast cancer drug and biosimilar, technology consulting, and other services. The company was founded on May 13, 2008 and is headquartered in Daejeon, South Korea.

Metrics

Overview

  • HQDaejeon, DE
  • SectorHealth Technology
  • IndustryBiotechnology
  • Ticker196170
  • Price$240.755925+2.19%

Trading Information

  • Market Cap$12.83B
  • Float71.62%
  • Average Daily Volume (1m)710,616
  • Average Daily Volume (3m)918,093
  • EPS-$26.85

Company

  • Revenue$90.79B
  • Rev Growth (1yr)-71.24%
  • Net Income-$2.92B
  • Gross Margin79.43%
  • EBITDA Margin-49.51%
  • EBITDA-$6.06B
  • EV$14.82T
  • EV/Revenue163.29
  • P/EN/A
  • P/S186.79
Documents